Prosecution Insights
Last updated: November 04, 2026

Anabio Technologies Limited

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials

2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days

Analysis

Anabio Technologies Limited maintains a portfolio in the Chemistry & Materials technology area with 2 pending office actions. These actions are currently assigned to 2 distinct examiners, showing that the company's legal matters are not concentrated under a single individual. Furthermore, the work is divided among 2 distinct art units, which suggests the underlying technologies may involve different specialized classifications within the broader chemistry field.

The busiest examiner identified in the data is LI, CHANGQING. This specific examiner is currently overseeing 1 pending office action for the company. Because there are 2 pending office actions in total, LI, CHANGQING is managing 1 of the active prosecution matters for Anabio Technologies Limited. The distribution across 2 distinct art units and 2 distinct examiners implies that the company must navigate different examination styles and departmental standards simultaneously.

Practitioners should note that with 1 pending action assigned to the busiest examiner, the other action is handled by a different examiner. This distribution of 2 pending actions across 2 distinct examiners reflects a decentralized prosecution environment for the current cases. Monitoring the specific requirements of both distinct art units will be necessary to ensure consistent results across the Chemistry & Materials portfolio.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

2
Total Pending OAs
1
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

2
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)2 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

20 h
Manual time on pending OAs
4 h
Time saved (low, 20%)
7 h
Time saved (mid, 35%)
0.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
LI, CHANGQING 1 29.6% +33.1%
STEINKE, SEAN JAMES 1 11.8% +43.3%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18096404 SOLUTION OF DENATURED PEA PROTEIN, AND USES THEREOF TO FORM MICROPARTICLES LI, CHANGQING 91d overdue
17801079 COATED MICROCAPSULES AND METHODS FOR THE PRODUCTION THEREOF STEINKE, SEAN JAMES —

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18096404 SOLUTION OF DENATURED PEA PROTEIN, AND USES THEREOF TO FORM MICROPARTICLES LI, CHANGQING 91d overdue
17801079 COATED MICROCAPSULES AND METHODS FOR THE PRODUCTION THEREOF STEINKE, SEAN JAMES —

Top Art Units

Art UnitApps
1791 1
1619 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18096404 SOLUTION OF DENATURED PEA PROTEIN, AND USES THEREOF TO FORM MICROPARTICLES LI, CHANGQING 1791 §103§112 Final Rejection 91d overdue Pending Jan 12, 2023
17801079 COATED MICROCAPSULES AND METHODS FOR THE PRODUCTION THEREOF STEINKE, SEAN JAMES 1619 §103§112 Non-Final OA — Pending Aug 19, 2022

Managing Anabio Technologies Limited's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Anabio Technologies Limited have?

Anabio Technologies Limited has 2 pending office actions as of November 2026, spread across 2 art units and 2 examiners.

Which USPTO examiner handles the most Anabio Technologies Limited applications?

Changqing Li has the most, with 1 of Anabio Technologies Limited's pending office actions.

What technology area are Anabio Technologies Limited's patent applications in?

Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month